These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26680953)

  • 1. Alterations in Promoter Usage and Expression Levels of Insulin-like Growth Factor-II and H19 Genes in Cervical and Endometrial Cancer.
    Lee C; Kim SJ; Na JY; Park CS; Lee SY; Kim IH; Oh YK
    Cancer Res Treat; 2003 Aug; 35(4):314-22. PubMed ID: 26680953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II.
    Kim SJ; Park SE; Lee C; Lee SY; Jo JH; Kim JM; Oh YK
    Biochim Biophys Acta; 2002 Apr; 1586(3):307-15. PubMed ID: 11997082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
    Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
    Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
    Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
    Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases.
    Kim SJ; Park SE; Lee C; Lee SY; Kim IH; An HJ; Oh YK
    Gynecol Oncol; 2003 Mar; 88(3):411-8. PubMed ID: 12648595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors.
    Nonomura N; Miki T; Nishimura K; Kanno N; Kojima Y; Okuyama A
    J Urol; 1997 May; 157(5):1977-9. PubMed ID: 9112575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of IGF2 and H19 imprinting in human brain.
    Pham NV; Nguyen MT; Hu JF; Vu TH; Hoffman AR
    Brain Res; 1998 Nov; 810(1-2):1-8. PubMed ID: 9813220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
    Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
    Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of imprinting in hepatoblastoma.
    Rainier S; Dobry CJ; Feinberg AP
    Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic imprinting of H19 and insulin-like growth factor-2 in pediatric germ cell tumors.
    Ross JA; Schmidt PT; Perentesis JP; Davies SM
    Cancer; 1999 Mar; 85(6):1389-94. PubMed ID: 10189147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor.
    Yballe CM; Vu TH; Hoffman AR
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach.
    Stier S; Neuhaus T; Albers P; Wernert N; Grünewald E; Forkert R; Vetter H; Ko Y
    Arch Toxicol; 2006 Oct; 80(10):713-8. PubMed ID: 16721595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer.
    Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
    Clin Cancer Res; 2000 Feb; 6(2):474-9. PubMed ID: 10690526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF2 but not H19 shows loss of imprinting in human glioma.
    Uyeno S; Aoki Y; Nata M; Sagisaka K; Kayama T; Yoshimoto T; Ono T
    Cancer Res; 1996 Dec; 56(23):5356-9. PubMed ID: 8968084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma.
    Kim KS; Lee YI
    Cancer Lett; 1997 Nov; 119(2):143-8. PubMed ID: 9570364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of imprinting of igf2 in renal-cell carcinomas.
    Oda H; Kume H; Shimizu Y; Inoue T; Ishikawa T
    Int J Cancer; 1998 Jan; 75(3):343-6. PubMed ID: 9455791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers.
    Kondo M; Suzuki H; Ueda R; Osada H; Takagi K; Takahashi T; Takahashi T
    Oncogene; 1995 Mar; 10(6):1193-8. PubMed ID: 7700644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma.
    Wu MS; Wang HP; Lin CC; Sheu JC; Shun CT; Lee WJ; Lin JT
    Cancer Lett; 1997 Nov; 120(1):9-14. PubMed ID: 9570380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of imprinting and promoter usage of the IGF2 in laryngeal squamous cell carcinoma.
    Grbesa I; Ivkic M; Pegan B; Gall-Troselj K
    Cancer Lett; 2006 Jul; 238(2):224-9. PubMed ID: 16111804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
    Vu TH; Hoffman A
    J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.